GNFTF Projected Dividend Yield
GENFIT SA ( OTCBB : GNFTF )GENFIT is a late-stage clinical biopharmaceutical company focused on the discovery and development of drug candidates and diagnostic solutions targeting metabolic and liver-related diseases. Co. is engaged in the field of nuclear receptor-based drug discovery. Co. is evaluating its primary drug candidate, elafibranor, as a potential treatment for primary biliary cholangitis. Co. is also conducting pre-clinical research, notably on NTZ, which could be repositioned for the treatment of liver fibrosis. 20 YEAR PERFORMANCE RESULTS |
GNFTF Dividend History Detail GNFTF Dividend News GNFTF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |